The corticotropin-releasing factor-hypocretin connection: Implications in stress response and addiction

Drug News and Perspectives

Volumn 18, Issue 4, 2005, Pages 250-255

  Paneda C ^a   Winsky Sommerer, R ^a   Boutrel, B ^a,b   De Lecea, L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AGOUTI RELATED PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DOPAMINE; GLUCOSE; GLUTAMIC ACID; LEPTIN; NEUROPEPTIDE; NEUROPEPTIDE Y; NORADRENALIN; OREXIN; OREXIN A; OREXIN B; SEROTONIN; TETRODOTOXIN;

ALERTNESS; ALLOSTASIS; AMYGDALOID NUCLEUS; AROUSAL; EX VIVO STUDY; HOMEOSTASIS; MOTIVATION; NARCOLEPSY; NONHUMAN; REGULATORY MECHANISM; REVIEW; STRESS; THALAMUS MIDLINE NUCLEUS;

AMYGDALA; ANIMALS; AROUSAL; BEHAVIOR, ADDICTIVE; CORTICOTROPIN-RELEASING HORMONE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOTIVATION; NEUROPEPTIDES; STRESS, PSYCHOLOGICAL;

EID: 23244433223     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2005.18.4.908659     Document Type: Review

References (61)

1. de Lecea, L. et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998, 95: 322-7.
2. Sakurai, T. et al. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92: 573-85.
3. Sutcliffe, J.G. and De Lecea, L. The hypocretins: Setting the arousal threshold. Nat Rev Neurosci 2002, 3: 339-49.
4. Gautvik, K.M., de Lecea, L., Gautvik, V.T. et al. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 1996, 93: 8733-8.
5. Trivedi, P., Yu, H., MacNeil, D.J., Van der Ploeg, L.H. and Guan, X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998, 438: 71-5.
6. Marcus, J.N., Aschkenasi, C.J., Lee, C.E. et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435: 6-25.
7. Lu, X.Y., Bagnol, D., Burke, S., Akil, H. and Watson, S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 2000, 37: 335-44.
8. van den Pol, A.N., Gao, X.B., Obrietan, K., Kilduff, T.S. and Belousov, A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998, 18: 7962-71.
9. Sherin, J.E., Shiromani, P.J., McCarley, R.W. and Saper, C.B. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271: 216-9.
10. Hagan, J.J. et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999, 96: 10911-6.
11. van den Pol, A.N. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord. J Neurosci 1999, 19: 3171-82.
12. Sweet, D.C., Levine, A.S., Billington, C.J. and Kotz, C.M. Feeding response to central orexins. Brain Res 1999, 821: 535-8.
13. Kunii, K., Yamanaka, A., Nambu, T., Matsuzaki, I., Goto, K. and Sakurai, T. Orexins/ hypocretins regulate drinking behaviour. Brain Res 1999, 842: 256-61.
14. Samson, W.K., Gosnell, B., Chang, J.K., Resch, Z.T. and Murphy, T.C. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res 1999, 831: 248-53.
15. Scammell, T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003, 53: 154-66.
16. Lin, L., Faraco, J., Li, R. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98: 365-76.
17. Chemelli, R.M. et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999, 98: 437-51.
18. Mochizuki, T., Crocker, A., McCormack, S., Yanagisawa, M., Sakurai, T. and Scammell, T.E. Behavioral state instability in orexin knock-out mice. J Neurosci 2004, 24: 6291-300.
19. Hara, J., Beuckmann, C.T., Nambu, T. et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30: 345-54.
20. Beuckmann, C.T., Sinton, C.M., Williams, S.C. et al. Expression of a poly-glutamineataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004, 24: 4469-77.
21. Ida, T., Nakahara, K., Katayama, T., Murakami, N. and Nakazato, M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 1999, 821: 526-9.
22. Rodgers, R.J., Halford, J.C., Nunes de Souza, R.L. et al. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept 2000, 96: 71-84.
23. Nakamura, T., Uramura, K., Nambu, T. et al. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 2000, 873: 181-7.
24. Ishii, Y., Blundell, J.E., Halford, J.C. et al. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiol Behav 2004, 81: 129-40.
25. Kuru, M., Ueta, Y., Serino, R. et al. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 2000, 11: 1977-80.
26. Blanco, M., Garcia-Caballero, T., Fraga, M. et al. Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas. Regul Pept 2002, 104: 161-5.
27. Lopez, M., Senaris, R., Gallego, R. et al. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 1999, 140: 5991-4.
28. Nanmoku, T., Isobe, K., Sakurai, T. et al. Effects of orexin on cultured porcine adrenal medullary and cortex cells. Regul Pept 2002, 104: 125-30.
29. Ida, T., Nakahara, K., Murakami, T., Hanada, R., Nakazato, M. and Murakami, N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 2000, 270: 318-23.
30. Espana, R.A., Valentine, R.J. and Berridge, C.W. Fos expression in hypocretin-1 receptor-bearing and hypocretin-synthesizing neurons: Effects of diurnal and nocturnal waking, stress and hcrt-1 administration. Abstract Viewer/Itinerary Planner. Society for Neuroscience 2002: Program No. 776.5.
31. Samson, W.K. and Taylor, M.M. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol Regul Integr Comp Physiol 2001, 281: R1140-5.
32. Shirasaka, T., Miyahara, S., Kunitake, T. et al. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol Regul Integr Comp Physiol 2001, 281: R1114-8.
33. Follwell, M.J. and Ferguson, A.V. Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J Physiol 2002, 545(Pt 3): 855-67.
34. Samson, W.K., Taylor, M.M., Follwell, M. and Ferguson, A.V. Orexin actions in hypothalamic paraventricular nucleus: Physiological consequences and cellular correlates. Regul Pept 2002, 104: 97-103.
35. Winsky-Sommerer, R., Yamanaka, A., Diano, S. et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): A novel circuit mediating stress response. J Neurosci 2004, 24: 11439-48.
36. Li, Y, Gao, X.B., Sakurai, T. and van den Pol, A.N. Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002, 36: 1169-81.
37. Reyes, T.M., Walker, J.R., DeCino, C., Hogenesch, J.B. and Sawchenko, P.E. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 2003, 23: 5607-16.
38. Alheid, G.F. and Heimer, L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticipetal components of substantia innominata. Neuroscience 1988, 27: 1-39.
39. Peyron, C., Tighe, D.K., van den Pol, A.N. et al. Neurons containing hypocretin (Orexin) project to multiple neuronal systems. J Neurosci 1998, 18: 9996-10015.
40. Baldo, B.A., Daniel, R.A., Berridge, C.W. and Kelley, A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 2003, 464: 220-37.
41. Erb, S., Salmaso, N., Rodaros, D. and Stewart, J. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 2001, 158: 360-5.
42. Erb, S., Shaham, Y. and Stewart, J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 1996, 128: 408-12.
43. Leri, F., Flores, J., Rodaros, D. and Stewart, J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 2002, 22: 5713-8.
44. Heinrichs, S.C. and Koob, G.F. Corticotropin-releasing factor in brain: A role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 2004, 311: 427-40.
45. Koob, G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann NY Acad Sci 1999, 877: 445-60.
46. Koob, G.F. Hedonic valence, dopamine and motivation. Mol Psychiatry 1996, 1: 186-9.
47. Koob, G.F. and Heinrichs, S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 1999, 848: 141-52.
48. Koob, G.F. and Le Moal, M. Drug abuse: Hedonic homeostatic dysregulation. Science 1997, 278: 52-8.
49. Koob, G.F., Sanna, P.P. and Bloom, F.E. Neuroscience of addiction. Neuron 1998, 21: 467-76.
50. Boutrel, B., Kenny, P.J., Specio, S.E., Markou, A., Koob, G.F. and de Lecea, L. Hypocretin regulates brain reward function and reinstatement of cocaine seeking behavior in rats. Soc Neurosci Abstr 2004, 573: 2.
51. Georgescu, D., Zachariou, V., Barrot, M. et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003, 23: 3106-11.
52. Shalev, U., Morales, M., Hope, B., Yap, J. and Shaham, Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology 2001, 156: 98-107.
53. Olds, J. and Milner, P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954, 47: 419-27.
54. Anand, B.K. and Brobeck, J.R. Localization of a feeding center in the hypothalamus of the rat. Proc Soc Exp Biol Med 1951, 77: 323-4.
55. Gallistel, C.R., Shizgal, P. and Yeomans, J.S. A portrait of the substrate for self-stimulation. Psychol Rev 1981, 88: 228-73.
56. Frank, R.A., Manderscheid, P.Z., Panicker, S., Williams, H.P. and Kokons, D. Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brain-stimulation reward. Pharmacol Biochem Behav 1992, 42: 771-9.
57. Epping-Jordan, M.P., Watkins, S.S., Koob, G.F. and Markou, A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 1998, 393: 76-9.
58. Kokkinidis, L. and McCarter, B.D. Postcocaine depression and sensitization of brain-stimulation reward: Analysis of reinforcement and performance effects. Pharmacol Biochem Behav 1990, 36: 463-71.
59. Macey, D.J., Koob, G.F. and Markou, A. CRF and urocortin decreased brain stimulation reward in the rat: Reversal by a CRF receptor antagonist. Brain Res 2000, 866: 82-91.
60. Roberts, A.J., Heyser, C.J., Cole, M., Griffin, P. and Koob, G.F. Excessive ethanol drinking following a history of dependence: Animal model of allostasis. Neuropsychopharmacology 2000, 22: 581-94.
61. Ahmed, S.H. and Koob, G.F. Transition from moderate to excessive drug intake: Change in hedonic set point. Science 1998, 282: 298-300.